<p>TOUYUN BIOTECH (01332.HK) announced its full-year results for the year ended last December, with revenue from the sale of goods and services amounting to HKD 71.948 million, a year-on-year decrease of 21.7%. It turned a loss into a profit of HKD 11.632 million, compared to a loss of HKD 78.899 million in the same period last year; earnings per share were HKD 0.0095. No dividend was declared</p>

159837

516930

159849

516500

01332

<p>TOUYUN BIOTECH announced its full-year results for the year ended December last year, with revenue from the sale of goods and services amounting to HKD 71.948 million, a year-on-year decrease of 21.7%. It turned a loss into a profit, earning HKD 11.632 million, compared to a loss of HKD 78.899 million in the same period last year; earnings per share were HKD 0.0095. No dividend was declared</p>

AASTOCKS

E Fund CSI Biotechnology Theme ETF

Minsheng Royal CSI Biotechnology Theme ETF

China Merchants CSI Biotechnology Theme ETF

ChinaAMC CSI Biotechnology Theme ETF

TOUYUN BIOTECH

First Trust NYSE Arca Biotech Index Fd

"Performance" TOUYUN BIOTECH turned a loss into a profit of 11.63 million yuan last year